DJIA 17,672.60 -141.38 -0.79%
NASDAQ 4,757.88 7.48 0.16%
S&P 500 2,051.82 -11.33 -0.55%
market minute promo

420.21 -0.60 (-0.14%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

REGN $420.21 -0.14%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $421.06
Previous Close $420.81
Daily Range $414.59 - $422.91
52-Week Range $267.56 - $437.64
Market Cap $42.7B
P/E Ratio 142.17
Dividend (Yield) $0.00 (0.0%)
Volume 388,267
Average Daily Volume 895,706
Current FY EPS $8.00

Sector

Healthcare

Industry

Drugs

Regeneron Pharmaceuticals, Inc. (REGN) Description

The Company is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions. Website: http://www.regeneron.com/

News & Commentary Rss Feed

5 Tiny Biotech Stocks to Own in 2015

Insys Therapeutics, Achillion Pharmaceuticals, Portola Pharmaceuticals, Ophthotech, and Acceleron Pharma have intriguing pipelines that may make them stocks to own this year.

Health Care Sector Update for 01/23/2015: REGN, ASPX, CELG

The 5 Biggest Biotech Stocks

Today's Momo Momentum Stock Is Regeneron Pharmaceuticals (REGN)

Alexion Pharmaceuticals Proves That Soliris Isn't Immune To Failure

Amgen Will Deliver In 2015

Biotech Stock Roundup: Shire to Acquire NPSP, Celgene & Pharmacyclics Give Strong Outlook - Analyst

Biotech Stock Roundup: Shire to Acquire NPSP, Celgene & Pharmacyclics Give Strong Outlook - Analyst Blog

Aegerion Reveals Preliminary 2014 Results and 2015 Outlook - Analyst Blog

Express Scripts CEO: Amgen, Regeneron, Cancer Drugs Next Targets for Drug Discounting

Trade-Ideas: Regeneron Pharmaceuticals (REGN) Is Today's Momo Momentum Stock

See More REGN News...

REGN's Top Competitors

REGN $420.21 (-0.14%)
Current stock: REGN
AMGN $159.81 (0.15%)
Current stock: AMGN
GILD $105.54 (0.38%)
Current stock: GILD
BIIB $357.63 (1.13%)
Current stock: BIIB